The role of patient satisfaction in methadone treatment.
BACKGROUND
Patient satisfaction surveys, widely used in health care delivery systems, may provide useful data for improving patient retention and outcomes.


OBJECTIVE
This study examined the relationship between methadone patients' treatment satisfaction at three months post-admission and their 3-month treatment outcomes and 12-month treatment retention.


METHODS
New methadone treatment admissions (N = 283) were assessed at 3 months post-admission for satisfaction with their counselors and programs. Correlations examined the relationship between 3-month satisfaction and Addiction Severity Index (ASI) scores. Regression analysis assessed the relationship between satisfaction and drug testing at 3 months and was used to predict whether participants were retained in treatment at 12 months.


RESULTS
Participants who were more satisfied with their counselors and programs had lower Drug and Legal ASI composite scores at 3 months. Participants who were more satisfied with their programs remained in treatment for at least 12 months.


CONCLUSIONS
Treatment programs should consider administering the CEF to their patients at 3 months post-admission to identify patients with low satisfaction scores who may be at risk for prematurely leaving treatment.


CONCLUSIONS
Measuring patient satisfaction during treatment may help programs meet patients' needs and improve retention.
Kelly
Sharon M
SM
Friends Research Institute, Inc., Baltimore, Maryland, USA. skelly@friendsresearch.org
O'Grady
Kevin E
KE
Brown
Barry S
BS
Mitchell
Shannon Gwin
SG
Schwartz
Robert P
RP
D000328:Adult; D005260:Female; D005500:Follow-Up Studies; D019538:Health Care Surveys; D006801:Humans; D008297:Male; D008691:Methadone / Q000627:therapeutic use*; D009294:Narcotics / Q000627:therapeutic use*; D009293:Opioid-Related Disorders / Q000523:psychology / Q000534:rehabilitation*; D017060:Patient Satisfaction / Q000706:statistics & numerical data*; D012044:Regression Analysis; D012720:Severity of Illness Index; D013997:Time Factors; D016896:Treatment Outcome
D009294:Narcotics; D008691:Methadone
J Subst Abuse Treat. 2004 Sep;27(2):99-121
15450644
J Behav Health Serv Res. 2002 Aug;29(3):345-56
12216378
Drug Alcohol Rev. 2008 Mar;27(2):138-44
18264873
Drug Alcohol Rev. 2008 Nov;27(6):671-8
19378450
J Subst Abuse Treat. 2002 Jun;22(4):183-96
12072163
Am J Drug Alcohol Abuse. 2009;35(1):38-42
19152205
Milbank Q. 1996;74(1):51-85
8596524
Addiction. 2000 Nov;95 Suppl 3:S347-60
11132362
J Subst Abuse Treat. 1992;9(3):199-213
1334156
Am J Psychiatry. 1995 Sep;152(9):1302-8
7653685
Am J Drug Alcohol Abuse. 2008;34(1):17-28
18161640
J Subst Abuse Treat. 1997 Nov-Dec;14(6):565-72
9437628
J Health Psychol. 2008 Apr;13(3):388-400
18420772
J Subst Abuse. 1995;7(1):117-34
7655308
Health Mark Q. 2007;24(1-2):93-106
19042522
Drug Alcohol Depend. 2005 Sep 1;79(3):405-12
15869846